Fellowships Program

Don't Delay Putting in your Application!

NCCRED has developed a multidisciplinary mentoring and training program. Fellows can be of any multidisciplinary background (e.g. Nursing, Allied Health, Medical), and fellowships will be open to practising clinicians in the Alcohol and Other Drugs sector.

Applications for the NCCRED Fellowship Program are now open and close 30th June.

Key Dates

Applications open: 15 May 19

Applications close: 30 Jun 19

Applications reviewed: 2 Jul 19

Interview period: 03-10 Jul 19

NCCRED Board reviews recommendations: 11 Jul 19

Acceptance Notification: 15 Jul 19

Deadline for Acceptance: 25 Jul 19

Fellowship Begins: 1 Feb 20 (rolling not fixed)

Are you going to APSAD?

Don't miss the NCCRED Symposium which is being held as part of APSAD on Sunday 10th November 2019 in Hobart at the Hotel Grand Chancellor Hobart.

Stay tuned for more information or if you have any questions let us know.

Email Us

Round 3 Grant Applications are now open!

NCCRED is releasing Grants to fund innovative Clinical Research for the treatment of substance use disorder due to methamphetamine or emerging drugs of concern.

$500,000 is available in Round 3 of funding! Applications close on 30th July.

Key Dates

Applications open: 15 May 19

Applications close: 30 Jul 19

Applications reviewed: 04 Sep 19

NCCRED Board awards funding: 26 Sep 19

Applicants are notified of results: 1 Oct 19

Final study report due to NCCRED: 1 Apr 2021

Click here for guidelines and application forms

Find out More

Funding

This funding will provide financial support as a seed-funding grant to establish investigator-initiated research.

Grant applications will be reviewed by the independent NCCRED Methamphetamine and Emerging Drugs Working Group and presented to the NCCRED Board for support of funding. For more information on the Grants funding process, to access the guidelines and application form or to contact us with any questions, please follow the link below.

The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions

The National Centre for Clinical Research on Emerging Drugs of Concern is Funded By